Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $277k | 215k | 1.29 |
| 2025-09-30 | $1.4M | 850k | 1.62 |
| 2025-06-30 | $2.2M | 1.7M | 1.29 |
| 2025-03-31 | $1.2M | 1.0M | 1.16 |
| 2024-12-31 | $534k | 500k | 1.07 |
| 2024-09-30 | $702k | 600k | 1.17 |
| 2024-06-30 | $647k | 600k | 1.08 |
| 2024-03-31 | $566k | 600k | 0.94 |
| 2023-12-31 | $593k | 600k | 0.99 |
| 2023-09-30 | $557k | 600k | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1